Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC

The First Affiliated Hospital with Nanjing Medical University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
metastatic prostate cancer, intermitent anti-androgen therapy, triple treatment regimen, mhpsc, darolutemide, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 802533
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.